Artelo Biosciences ARTL
NASDAQ ARTL
$4.08 +0.01 (+0.25%)
As of: Sep 30, 2026 · 3:59 PM EDT

Artelo Biosciences (ARTL) Share-based Compensation (IS) (2017)

Updated

Artelo Biosciences' Share-based Compensation (IS) came in at $1,666 for Q4 2017, unchanged from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Share-based Compensation (IS) (2017) Analysis & Trends

For FY2017, Artelo Biosciences' Share-based Compensation (IS) was $3,332.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Artelo Biosciences 81,090.68 -5.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2017 1,666.00
May 31, 2017 1,666.00
API Access

Artelo Biosciences Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ARTL&period=max&api_key=YOUR_API_KEY